This is going to be a hard but hopefully enlightening lesson for many. I have seen it play out so many times. It will start when CCAA concludes and there is nothing about any transaction involving the equity of the company. It will continue when the Delaware process starts back up in order to clear out the remaining issues re: BioAmber Inc. And it will ultimately end when the share cancellation shows up on the dailylist. Until then, hope does spring eternal in the OTC.